NO306397B1 - 15-deoksyspergualinanaloger, mellomprodukter for deres fremstilling, deres anvendelse samt farmasöytiske preparater - Google Patents
15-deoksyspergualinanaloger, mellomprodukter for deres fremstilling, deres anvendelse samt farmasöytiske preparaterInfo
- Publication number
- NO306397B1 NO306397B1 NO961891A NO961891A NO306397B1 NO 306397 B1 NO306397 B1 NO 306397B1 NO 961891 A NO961891 A NO 961891A NO 961891 A NO961891 A NO 961891A NO 306397 B1 NO306397 B1 NO 306397B1
- Authority
- NO
- Norway
- Prior art keywords
- intermediates
- deoxypergualin
- analogs
- preparation
- pharmaceutical preparations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
- C07C215/14—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic the nitrogen atom of the amino group being further bound to hydrocarbon groups substituted by amino groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/12—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/24—Y being a hetero atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Transplantation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9505862A FR2734263B1 (fr) | 1995-05-17 | 1995-05-17 | Analogues de la 15-deoxyspergualine, leur procede de preparation et leur utilisation en therapeutique |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO961891D0 NO961891D0 (no) | 1996-05-10 |
| NO961891L NO961891L (no) | 1996-11-18 |
| NO306397B1 true NO306397B1 (no) | 1999-11-01 |
Family
ID=9479086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO961891A NO306397B1 (no) | 1995-05-17 | 1996-05-10 | 15-deoksyspergualinanaloger, mellomprodukter for deres fremstilling, deres anvendelse samt farmasöytiske preparater |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5733928A (no) |
| EP (1) | EP0743300B1 (no) |
| JP (1) | JP2860778B2 (no) |
| KR (1) | KR960041153A (no) |
| CN (1) | CN1063744C (no) |
| AT (1) | ATE182882T1 (no) |
| AU (1) | AU694342B2 (no) |
| CA (1) | CA2176670C (no) |
| CZ (1) | CZ292373B6 (no) |
| DE (1) | DE69603541T2 (no) |
| DK (1) | DK0743300T3 (no) |
| ES (1) | ES2137634T3 (no) |
| FR (1) | FR2734263B1 (no) |
| GR (1) | GR3031684T3 (no) |
| HU (1) | HUP9601323A3 (no) |
| NO (1) | NO306397B1 (no) |
| NZ (1) | NZ286582A (no) |
| RU (1) | RU2130015C1 (no) |
| SK (1) | SK283372B6 (no) |
| TW (1) | TW354782B (no) |
| UA (1) | UA42798C2 (no) |
| ZA (1) | ZA963775B (no) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843995A (en) * | 1997-07-07 | 1998-12-01 | University Of Medicine And Dentistry Of New Jersey | Inhibition of HIV-1 replication using oligocarbamate derivatives |
| DE19737463A1 (de) * | 1997-08-28 | 1999-03-04 | Hoechst Marion Roussel De Gmbh | Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden |
| DE19923961A1 (de) * | 1999-05-25 | 2000-11-30 | Euro Nippon Kayaku Gmbh | Verwendung von 15-Deoxyspergualin zur Behandlung von hyperreaktiven entzündlichen Erkrankungen und Autoimmunerkrankungen |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5942356A (ja) * | 1982-09-02 | 1984-03-08 | Microbial Chem Res Found | スパガリン関連化合物およびその製造法 |
| JPS61129119A (ja) * | 1984-11-13 | 1986-06-17 | Microbial Chem Res Found | 新規免疫抑制剤 |
| US4990536A (en) * | 1989-04-03 | 1991-02-05 | Nippon Kayaku Kabushiki Kaisha | Immunopotentiator and spergualin-related compound therefor |
| FR2698628B1 (fr) * | 1992-12-02 | 1995-02-17 | Fournier Ind & Sante | Analogues de 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique. |
| FR2716452B1 (fr) * | 1994-02-24 | 1996-05-10 | Fournier Ind & Sante | Analogues de la 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique. |
-
1995
- 1995-05-17 FR FR9505862A patent/FR2734263B1/fr not_active Expired - Fee Related
-
1996
- 1996-05-03 AT AT96400949T patent/ATE182882T1/de not_active IP Right Cessation
- 1996-05-03 DE DE69603541T patent/DE69603541T2/de not_active Expired - Fee Related
- 1996-05-03 ES ES96400949T patent/ES2137634T3/es not_active Expired - Lifetime
- 1996-05-03 EP EP96400949A patent/EP0743300B1/fr not_active Expired - Lifetime
- 1996-05-03 DK DK96400949T patent/DK0743300T3/da active
- 1996-05-06 AU AU52081/96A patent/AU694342B2/en not_active Ceased
- 1996-05-07 UA UA96051800A patent/UA42798C2/uk unknown
- 1996-05-10 NO NO961891A patent/NO306397B1/no not_active IP Right Cessation
- 1996-05-10 TW TW085105514A patent/TW354782B/zh active
- 1996-05-13 ZA ZA963775A patent/ZA963775B/xx unknown
- 1996-05-15 NZ NZ286582A patent/NZ286582A/en unknown
- 1996-05-15 US US08/647,813 patent/US5733928A/en not_active Expired - Fee Related
- 1996-05-15 CA CA002176670A patent/CA2176670C/en not_active Expired - Fee Related
- 1996-05-16 RU RU96109193/04A patent/RU2130015C1/ru not_active IP Right Cessation
- 1996-05-16 CN CN96105030A patent/CN1063744C/zh not_active Expired - Fee Related
- 1996-05-16 CZ CZ19961423A patent/CZ292373B6/cs not_active IP Right Cessation
- 1996-05-16 HU HU9601323A patent/HUP9601323A3/hu unknown
- 1996-05-16 SK SK636-96A patent/SK283372B6/sk unknown
- 1996-05-17 JP JP8148384A patent/JP2860778B2/ja not_active Expired - Fee Related
- 1996-05-17 KR KR1019960016609A patent/KR960041153A/ko not_active Abandoned
-
1999
- 1999-10-29 GR GR990402774T patent/GR3031684T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ286582A (en) | 1998-07-28 |
| HU9601323D0 (en) | 1996-07-29 |
| CZ142396A3 (en) | 1997-02-12 |
| CA2176670C (en) | 2002-03-26 |
| NO961891D0 (no) | 1996-05-10 |
| EP0743300A1 (fr) | 1996-11-20 |
| UA42798C2 (uk) | 2001-11-15 |
| CN1143075A (zh) | 1997-02-19 |
| DE69603541T2 (de) | 2000-04-06 |
| ATE182882T1 (de) | 1999-08-15 |
| FR2734263B1 (fr) | 1997-06-20 |
| US5733928A (en) | 1998-03-31 |
| NO961891L (no) | 1996-11-18 |
| JP2860778B2 (ja) | 1999-02-24 |
| AU694342B2 (en) | 1998-07-16 |
| HUP9601323A3 (en) | 1998-04-28 |
| SK283372B6 (sk) | 2003-06-03 |
| GR3031684T3 (en) | 2000-02-29 |
| ES2137634T3 (es) | 1999-12-16 |
| FR2734263A1 (fr) | 1996-11-22 |
| DK0743300T3 (da) | 2000-01-24 |
| AU5208196A (en) | 1996-11-28 |
| TW354782B (en) | 1999-03-21 |
| KR960041153A (ko) | 1996-12-19 |
| EP0743300B1 (fr) | 1999-08-04 |
| CN1063744C (zh) | 2001-03-28 |
| DE69603541D1 (de) | 1999-09-09 |
| HUP9601323A2 (en) | 1997-05-28 |
| RU2130015C1 (ru) | 1999-05-10 |
| CZ292373B6 (cs) | 2003-09-17 |
| ZA963775B (en) | 1996-11-25 |
| SK63696A3 (en) | 1996-12-04 |
| JPH0977733A (ja) | 1997-03-25 |
| CA2176670A1 (en) | 1996-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0444659T3 (da) | Farmaceutisk opløsning indeholdende derivater af FK 506 | |
| FI914928A0 (fi) | Hydroximetyl (metylencyklopentyl) puriner och -pyrimidiner. | |
| EP0303697A4 (en) | Derivatives of physiologically active substance k-252. | |
| ES553936A0 (es) | Un procedimiento para la preparacion de nuevas n-((4-piperidinil)alquil)oxazol y tiazolaminas condensadas biciclicas sustituidas | |
| DK232989A (da) | Antiviralt praeparat | |
| GB8525913D0 (en) | Compounds | |
| FI884070A0 (fi) | Rytmstoerningar foerhindrande medel. | |
| DE68912438D1 (de) | Antifungale Antibiotika. | |
| DK160488D0 (da) | Aebenzazepinsulfonamid-forbindelser, deres anvendelse til fremstilling af antiarrhythmia-laegemidler og farmaceutiske praeparater indeholdende sulfonamiderne samt benzazepin-forbindelser, der er nyttige som mellemprodukterae | |
| ZA858659B (en) | Use of spergualin derivatives for the preparation of medicaments having immunosuppressive activity | |
| NO961891L (no) | 15-deoksyspergualinanaloger, deres fremstilling og anvendelse | |
| GR861214B (en) | Herbicidal o- carbomethoxysulfonylureas | |
| ES2071667T3 (es) | Derivados de anfotericina b. | |
| GB9218113D0 (en) | Pharmaceutical compounds | |
| FI904449A0 (fi) | N-azasicyklo/3.3.0/oktanamider av aromatiska syror. | |
| PT98186A (pt) | Processo para a preparacao de purinil- e de pirimidinil-tetra-hidrofuranos e de composicoes farmaceuticas que os contem | |
| FI873145A0 (fi) | Nya tetracykliska indolderivat. | |
| ES2141134T3 (es) | Derivados de carbamoil pirrolidona para el tratamiento de la depresion y de los trastornos cerebrovasculares. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |